Ticker LaunchSPAC · Searching for a target · BREZ
Breeze Acquisition Corp. II
Breeze Acquisition Corp. II (BREZ) is a blank-check company (SPAC) that raised $125M in its initial public offering on May 14, 2026, listing on Nasdaq. It has not announced a definitive business combination agreement. YD Biopharma led the IPO, with YD Bio. ArentFox Schiff advised the SPAC and A&O Shearman advised the underwriters on the IPO.
- Status
- Searching for a target
- Ticker
- BREZ
- IPO date
- May 14, 2026
- IPO size
- $125M
- IPO exchange
- Nasdaq
- IPO underwriters
- YD Biopharma and YD Bio
- SPAC counsel (IPO)
- ArentFox Schiff and Ogier
- Underwriters' counsel (IPO)
- A&O Shearman
More on this SPAC for subscribers
- Trust balance and value per share
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) May 14, 2026
- All filings on EDGAR CIK 2095443
Other SPAC IPOs from 2026
- Berto Acquisition Corp. IIMay 18, 2026 · $274M
- Patriot Acquisition Corp./CIMay 18, 2026 · $160M
- Energy Transition Special OpportunitiesMay 15, 2026 · $150M
- Iron Dome Acquisition I Corp.May 15, 2026 · $150M
- GSR V Acquisition Corp.May 14, 2026 · $200M
- Starlink AI Acquisition CorpMay 8, 2026 · $100M